| UniProt ID | LDB1_HUMAN | |
|---|---|---|
| UniProt AC | Q86U70 | |
| Protein Name | LIM domain-binding protein 1 | |
| Gene Name | LDB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 411 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Binds to the LIM domain of a wide variety of LIM domain-containing transcription factors. May regulate the transcriptional activity of LIM-containing proteins by determining specific partner interactions. Plays a role in the development of interneurons and motor neurons in cooperation with LHX3 and ISL1. Acts synergistically with LHX1/LIM1 in axis formation and activation of gene expression. Acts with LMO2 in the regulation of red blood cell development, maintaining erythroid precursors in an immature state (By similarity).. | |
| Protein Sequence | MSVGCACPGCSSKSFKLYSPKEPPNGNAFPPFHPGTMLDRDVGPTPMYPPTYLEPGIGRHTPYGNQTDYRIFELNKRLQNWTEECDNLWWDAFTTEFFEDDAMLTITFCLEDGPKRYTIGRTLIPRYFRSIFEGGATELYYVLKHPKEAFHSNFVSLDCDQGSMVTQHGKPMFTQVCVEGRLYLEFMFDDMMRIKTWHFSIRQHRELIPRSILAMHAQDPQMLDQLSKNITRCGLSNSTLNYLRLCVILEPMQELMSRHKTYSLSPRDCLKTCLFQKWQRMVAPPAEPTRQQPSKRRKRKMSGGSTMSSGGGNTNNSNSKKKSPASTFALSSQVPDVMVVGEPTLMGGEFGDEDERLITRLENTQFDAANGIDDEDSFNNSPALGANSPWNSKPPSSQESKSENPTSQASQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSVGCACPG ------CCCCCCCCC | 27.50 | 19413330 | |
| 2 | Phosphorylation | ------MSVGCACPG ------CCCCCCCCC | 27.50 | 24043423 | |
| 11 | Phosphorylation | GCACPGCSSKSFKLY CCCCCCCCCCCEEEE | 46.87 | 24043423 | |
| 12 | Phosphorylation | CACPGCSSKSFKLYS CCCCCCCCCCEEEEC | 36.07 | 24043423 | |
| 13 | Acetylation | ACPGCSSKSFKLYSP CCCCCCCCCEEEECC | 43.55 | 25953088 | |
| 16 | Acetylation | GCSSKSFKLYSPKEP CCCCCCEEEECCCCC | 54.31 | 25953088 | |
| 18 | Phosphorylation | SSKSFKLYSPKEPPN CCCCEEEECCCCCCC | 24.42 | 28122231 | |
| 19 | Phosphorylation | SKSFKLYSPKEPPNG CCCEEEECCCCCCCC | 39.67 | 24719451 | |
| 25 (in isoform 2) | Phosphorylation | - | 68.04 | - | |
| 45 | Phosphorylation | LDRDVGPTPMYPPTY CCCCCCCCCCCCCCC | 18.11 | 26074081 | |
| 48 | Phosphorylation | DVGPTPMYPPTYLEP CCCCCCCCCCCCCCC | 13.78 | 26074081 | |
| 51 | Phosphorylation | PTPMYPPTYLEPGIG CCCCCCCCCCCCCCC | 35.91 | 23401153 | |
| 52 | Phosphorylation | TPMYPPTYLEPGIGR CCCCCCCCCCCCCCC | 18.16 | 26074081 | |
| 61 | Phosphorylation | EPGIGRHTPYGNQTD CCCCCCCCCCCCHHH | 19.49 | 23401153 | |
| 63 | Phosphorylation | GIGRHTPYGNQTDYR CCCCCCCCCCHHHHH | 29.84 | 26074081 | |
| 67 | Phosphorylation | HTPYGNQTDYRIFEL CCCCCCHHHHHHHHH | 38.71 | 26074081 | |
| 69 | Phosphorylation | PYGNQTDYRIFELNK CCCCHHHHHHHHHHH | 14.70 | 27251275 | |
| 76 | Ubiquitination | YRIFELNKRLQNWTE HHHHHHHHHHHHHHH | 68.08 | - | |
| 127 | Phosphorylation | GRTLIPRYFRSIFEG CCCHHHHHHHHHHCC | 9.67 | 26074081 | |
| 130 | Phosphorylation | LIPRYFRSIFEGGAT HHHHHHHHHHCCCCE | 23.02 | 26074081 | |
| 137 | Phosphorylation | SIFEGGATELYYVLK HHHCCCCEEEEEEEC | 29.78 | 26074081 | |
| 140 | Phosphorylation | EGGATELYYVLKHPK CCCCEEEEEEECCHH | 5.82 | 26074081 | |
| 141 | Phosphorylation | GGATELYYVLKHPKE CCCEEEEEEECCHHH | 16.36 | 26074081 | |
| 144 | Ubiquitination | TELYYVLKHPKEAFH EEEEEEECCHHHHHH | 48.06 | - | |
| 170 | Ubiquitination | SMVTQHGKPMFTQVC CEEECCCCEEEEEEE | 31.05 | - | |
| 225 (in isoform 2) | Phosphorylation | - | 43.61 | - | |
| 226 (in isoform 2) | Phosphorylation | - | 8.64 | - | |
| 260 | Ubiquitination | QELMSRHKTYSLSPR HHHHHHCCCCCCCHH | 48.31 | - | |
| 261 | Phosphorylation | ELMSRHKTYSLSPRD HHHHHCCCCCCCHHH | 16.53 | 19664994 | |
| 262 | Phosphorylation | LMSRHKTYSLSPRDC HHHHCCCCCCCHHHH | 16.65 | 19664994 | |
| 263 | Phosphorylation | MSRHKTYSLSPRDCL HHHCCCCCCCHHHHH | 27.83 | 29900121 | |
| 265 | Phosphorylation | RHKTYSLSPRDCLKT HCCCCCCCHHHHHHH | 16.37 | 23401153 | |
| 266 (in isoform 2) | Phosphorylation | - | 41.23 | - | |
| 270 (in isoform 2) | Phosphorylation | - | 6.36 | - | |
| 271 | Methylation | LSPRDCLKTCLFQKW CCHHHHHHHHHHHHH | 43.45 | 24494591 | |
| 271 | Ubiquitination | LSPRDCLKTCLFQKW CCHHHHHHHHHHHHH | 43.45 | - | |
| 277 | Ubiquitination | LKTCLFQKWQRMVAP HHHHHHHHHHHHCCC | 37.65 | - | |
| 280 | Methylation | CLFQKWQRMVAPPAE HHHHHHHHHCCCCCC | 22.04 | - | |
| 289 | Phosphorylation | VAPPAEPTRQQPSKR CCCCCCCCCCCCCHH | 32.39 | 26074081 | |
| 291 (in isoform 2) | Phosphorylation | - | 63.11 | - | |
| 294 | Phosphorylation | EPTRQQPSKRRKRKM CCCCCCCCHHCCCCC | 34.16 | 26074081 | |
| 302 | Phosphorylation | KRRKRKMSGGSTMSS HHCCCCCCCCCCCCC | 42.93 | 22167270 | |
| 305 | Phosphorylation | KRKMSGGSTMSSGGG CCCCCCCCCCCCCCC | 25.18 | 22167270 | |
| 306 | Phosphorylation | RKMSGGSTMSSGGGN CCCCCCCCCCCCCCC | 25.09 | 23401153 | |
| 308 | Phosphorylation | MSGGSTMSSGGGNTN CCCCCCCCCCCCCCC | 26.39 | 22167270 | |
| 309 | Phosphorylation | SGGSTMSSGGGNTNN CCCCCCCCCCCCCCC | 30.54 | 22167270 | |
| 314 | Phosphorylation | MSSGGGNTNNSNSKK CCCCCCCCCCCCCCC | 38.77 | 23663014 | |
| 317 | Phosphorylation | GGGNTNNSNSKKKSP CCCCCCCCCCCCCCC | 44.54 | 23663014 | |
| 319 | Phosphorylation | GNTNNSNSKKKSPAS CCCCCCCCCCCCCHH | 45.75 | 23663014 | |
| 323 | Phosphorylation | NSNSKKKSPASTFAL CCCCCCCCCHHHHHH | 34.28 | 25159151 | |
| 326 | Phosphorylation | SKKKSPASTFALSSQ CCCCCCHHHHHHCCC | 27.69 | 22210691 | |
| 327 | Phosphorylation | KKKSPASTFALSSQV CCCCCHHHHHHCCCC | 18.29 | 28102081 | |
| 331 | Phosphorylation | PASTFALSSQVPDVM CHHHHHHCCCCCCEE | 18.46 | 19276368 | |
| 332 | Phosphorylation | ASTFALSSQVPDVMV HHHHHHCCCCCCEEE | 35.73 | 27251275 | |
| 344 | Phosphorylation | VMVVGEPTLMGGEFG EEEECCCEECCCCCC | 25.69 | 27251275 | |
| 374 (in isoform 2) | Phosphorylation | - | 60.73 | - | |
| 377 | Phosphorylation | NGIDDEDSFNNSPAL CCCCCHHHCCCCCCC | 28.03 | 26074081 | |
| 381 | Phosphorylation | DEDSFNNSPALGANS CHHHCCCCCCCCCCC | 16.80 | 26074081 | |
| 388 | Phosphorylation | SPALGANSPWNSKPP CCCCCCCCCCCCCCC | 30.66 | 26074081 | |
| 392 | Phosphorylation | GANSPWNSKPPSSQE CCCCCCCCCCCCCCC | 42.54 | 26074081 | |
| 393 | Acetylation | ANSPWNSKPPSSQES CCCCCCCCCCCCCCC | 58.70 | 23236377 | |
| 396 | Phosphorylation | PWNSKPPSSQESKSE CCCCCCCCCCCCCCC | 53.86 | 26074081 | |
| 397 | Phosphorylation | WNSKPPSSQESKSEN CCCCCCCCCCCCCCC | 43.68 | 26074081 | |
| 400 | Phosphorylation | KPPSSQESKSENPTS CCCCCCCCCCCCCCC | 33.57 | 26074081 | |
| 402 | Phosphorylation | PSSQESKSENPTSQA CCCCCCCCCCCCCCC | 52.46 | 26074081 | |
| 406 | Phosphorylation | ESKSENPTSQASQ-- CCCCCCCCCCCCC-- | 45.08 | 26074081 | |
| 407 | Phosphorylation | SKSENPTSQASQ--- CCCCCCCCCCCC--- | 25.63 | 26074081 | |
| 407 | O-linked_Glycosylation | SKSENPTSQASQ--- CCCCCCCCCCCC--- | 25.63 | 30379171 | |
| 410 | O-linked_Glycosylation | ENPTSQASQ------ CCCCCCCCC------ | 28.87 | 30379171 | |
| 410 | Phosphorylation | ENPTSQASQ------ CCCCCCCCC------ | 28.87 | 23663014 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LDB1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LDB1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SSBP4_HUMAN | SSBP4 | physical | 16189514 | |
| LMO3_HUMAN | LMO3 | physical | 16189514 | |
| SSBP2_HUMAN | SSBP2 | physical | 16189514 | |
| TOLIP_HUMAN | TOLLIP | physical | 16189514 | |
| RBTN2_HUMAN | LMO2 | physical | 12727888 | |
| LMO4_HUMAN | LMO4 | physical | 12727888 | |
| TAL1_HUMAN | TAL1 | physical | 16407974 | |
| TFE2_HUMAN | TCF3 | physical | 16407974 | |
| MTG16_HUMAN | CBFA2T3 | physical | 16407974 | |
| ESR1_HUMAN | ESR1 | physical | 19117995 | |
| RNF12_HUMAN | RLIM | physical | 17437998 | |
| RBTN2_HUMAN | LMO2 | physical | 17437998 | |
| LHX2_HUMAN | LHX2 | physical | 20211142 | |
| RB_HUMAN | RB1 | physical | 10866689 | |
| RNF6_HUMAN | RNF6 | physical | 12874135 | |
| RNF38_HUMAN | RNF38 | physical | 12874135 | |
| RF12A_XENLA | rlim-a | physical | 12874135 | |
| PSD10_HUMAN | PSMD10 | physical | 21988832 | |
| RBTN2_HUMAN | LMO2 | physical | 21988832 | |
| PSA1_HUMAN | PSMA1 | physical | 21988832 | |
| LSM7_HUMAN | LSM7 | physical | 21988832 | |
| RPA2_HUMAN | POLR1B | physical | 21988832 | |
| SSBP3_HUMAN | SSBP3 | physical | 25416956 | |
| LHX6_HUMAN | LHX6 | physical | 25416956 | |
| LHX8_HUMAN | LHX8 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302 AND THR-306, ANDMASS SPECTROMETRY. | |